Company offers 50,000 common shares at $0.50 each to Autilion in deal
By Devika Patel
Knoxville, Tenn., June 28 - VistaGen Therapeutics, Inc. raised $25,000 in a private placement of stock with Autilion AG on June 27, according to an 8-K filed Friday with the Securities and Exchange Commission.
The company sold 50,000 common shares at $0.50 apiece. The per-share price represents a 16.67% discount to the June 26 closing share price of $0.60.
The company is a South San Francisco, Calif.-based biotechnology company focused on stem cells.
| Issuer: | VistaGen Therapeutics, Inc.
|
| Issue: | Common stock
|
| Amount: | $25,000
|
| Shares: | 50,000
|
| Price: | $0.50
|
| Warrants: | No
|
| Investor: | Autilion AG
|
| Settlement date: | June 27
|
| Stock symbol: | OTCBB: VSTA
|
| Stock price: | $0.60 at close June 26
|
| Market capitalization: | $12.05 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
